No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the Closing Date and, with respect to any Option Securities purchased after the Closing Date, each Option Closing Date, in the judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse Effect.
Appears in 6 contracts
Samples: Underwriting Agreement (Phio Pharmaceuticals Corp.), Underwriting Agreement (Phio Pharmaceuticals Corp.), Underwriting Agreement (Vaxart, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Optional Shares purchased after the First Closing Date, each Option Closing Date, in the judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 6 contracts
Samples: Underwriting Agreement (Cidara Therapeutics, Inc.), Underwriting Agreement (Cidara Therapeutics, Inc.), Underwriting Agreement (ACM Research, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Optional Securities purchased after the First Closing Date, each Option Closing Date, in the judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 6 contracts
Samples: Underwriting Agreement (AMCI Acquisition Corp. II), Underwriting Agreement (AMCI Acquisition Corp. II), Underwriting Agreement (AMCI Acquisition Corp. II)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Optional Shares purchased after the First Closing Date, each Option Closing Date, in the judgment of the Representative Representatives there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 5 contracts
Samples: Underwriting Agreement (Mirati Therapeutics, Inc.), Underwriting Agreement (Mirati Therapeutics, Inc.), Underwriting Agreement (Mirati Therapeutics, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including prior to the First Closing Date and, with respect to any Option Securities purchased after the Optional Common Shares, the Second Closing Date, each Option Closing Date, Date in the judgment of the Representative Representatives there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 4 contracts
Samples: Underwriting Agreement (California Pizza Kitchen Inc), Underwriting Agreement (JDS Uniphase Corp /Ca/), Underwriting Agreement (Data Critical Corp)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including prior to the First Closing Date and, with respect to any Option Securities purchased after the Closing DateOptional Common Shares, each Option the Second Closing Date, in the reasonable judgment of the Representative Representative, there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 3 contracts
Samples: Underwriting Agreement (CardioVascular BioTherapeutics, Inc.), Underwriting Agreement (CardioVascular BioTherapeutics, Inc.), Underwriting Agreement (CardioVascular BioTherapeutics, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Shares purchased after the First Closing Date, each Option Closing Date, in the judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse Effect.
Appears in 3 contracts
Samples: Underwriting Agreement (Navidea Biopharmaceuticals, Inc.), Underwriting Agreement (InspireMD, Inc.), Underwriting Agreement (InspireMD, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities purchased after the Closing DateOptional Shares, each Option Closing Date, in the judgment of the Representative Representatives there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 2 contracts
Samples: Underwriting Agreement (Green Plains Renewable Energy, Inc.), Underwriting Agreement (Green Plains Renewable Energy, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities purchased after the Closing DateOptional Shares, each Option Closing Date, Date in the judgment of the Representative Representatives there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 2 contracts
Samples: Underwriting Agreement (Power Medical Interventions, Inc.), Underwriting Agreement (Power Medical Interventions, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including prior to the First Closing Date and, with respect to any Option Securities purchased after the Closing DateOptional Common Shares, each Option the Second Closing Date, in the judgment of the Representative Representatives there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 2 contracts
Samples: Underwriting Agreement (McCormick & Schmicks Seafood Restaurants Inc.), Underwriting Agreement (Acorda Therapeutics Inc)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including prior to the First Closing Date and, with respect to any Option Securities purchased after the Closing DateOptional Shares, each Option Closing Date, Date in the judgment of the Representative Underwriters, there shall not have occurred any material adverse change in occurred, except as contemplated by the authorized capital stock of the Company or Prospectus, any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 2 contracts
Samples: Underwriting Agreement (Vantage Drilling CO), Underwriting Agreement (Vantage Drilling CO)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Optional Shares purchased after the First Closing Date, each Option Closing Date, in the judgment of the Representative Representatives there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse Effect.Change; and
Appears in 1 contract
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including prior to the First Closing Date and, with respect to any Option Securities purchased after the Optional Common Shares, the Second Closing Date, each Option Closing Date, Date in the reasonable judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 1 contract
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Optional Shares purchased after the First Closing Date, each Option Closing Date, :
(i) in the judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 1 contract
Samples: Underwriting Agreement (Green Plains Renewable Energy, Inc.)
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Optional Shares purchased after the First Closing Date, each Option Closing Date, :
(i) in the judgment of the Representative Representatives there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse Effect.Change; and
Appears in 1 contract
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Optional Shares purchased after the First Closing Date, each Option Closing Date, Date in the judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse EffectChange.
Appears in 1 contract
No Material Adverse Change or Ratings Agency Change. For the period from and after the date of this Agreement and through and including the First Closing Date and, with respect to any Option Securities Optional Shares purchased after the First Closing Date, each Option Closing Date, in the judgment of the Representative there shall not have occurred any material adverse change in the authorized capital stock of the Company or any Material Adverse Effect or any development that would cause a Material Adverse Effect.:
Appears in 1 contract
Samples: Underwriting Agreement (Parnell Pharmaceuticals Holdings Pty LTD)
